Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation

PURPOSE: Both epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy are widely applied for the treatment of advanced non-small-cell lung cancer (NSCLC) with EGFR mutations, and the combination of EGFR-TKIs and chemotherapy has been used for advanced NSCLC patients;...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Miaomiao, Xia, Jinghua, Sun, Ying, Wang, Xuejiao, Fu, Xianghui, Zhang, Yanning, Zhang, Zhipei, Zhou, Yongan, Li, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280904/
https://www.ncbi.nlm.nih.gov/pubmed/30555222
http://dx.doi.org/10.2147/BTT.S169305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280904/
https://www.ncbi.nlm.nih.gov/pubmed/30555222
http://dx.doi.org/10.2147/BTT.S169305

Ejemplares similares